bdunlap@newsandsentinel.com
WVU Medicine Camden Clark Medical Center is now offering the two leading monoclonal antibody therapies, Bamlanivimab and Casirivimab/Imdevimab, in the treatment of COVID-19. The I.V. treatment is being offered through an infusion clinic at the hospital, based the referral of a primary care physician. (File Photo)
PARKERSBURG WVU Medicine Camden Clark Medical Center is now offering the two leading monoclonal antibody therapies in the treatment of COVID-19.
The U.S. Food and Drug Administration issued an emergency use authorization for the investigational monoclonal antibody therapies Bamlanivimab and Casirivimab/Imdevimab. These are in addition to the vaccines that have begun to be administered nationwide.